Publications by authors named "Alex Fleishman"

Claim this Profile
A
A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies.
Michael J Koren, Peter H Jones, Jennifer G Robinson, David Sullivan, Leslie Cho, Alex N Fleishman

Cardiol Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
Hagop Kantarjian, Anthony Stein, Nicola Gökbuget, Adele K Fielding, Andre C Schuh, Alex Fleishman

N Engl J Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stopping guidelines for harm in a study designed to establish the safety of a marketed drug.
Alex N Fleishman, Robert A Parker

J Biopharm Stat· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia.
Heinz Ludwig, Jeffrey Crawford, Anders Osterborg, Johan Vansteenkiste, David H Henry, Alex Fleishman

J Clin Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease.
John A Glaspy, Jaswant Sinh Jadeja, Glen Justice, Alex Fleishman, Gregory Rossi

Cancer· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis